Disruptive Capital Finance

About Disruptive Capital Finance

Disruptive Capital Finance, also known as Disruptive Capital GP, is a venture capital fund based in London, United Kingdom, with expertise in equity investments. They have a notable track record for investing across a broad spectrum of industries, including Software, IT, Media, BioTech, Business Solutions, Hardware, Energy, Entertainment, CleanTech, HealthTech, Gaming, Advertising, Analytics, Logistics, Material Science, Payments, Mobile, Online Social, and Consumer sectors. Their investment thesis is built around sourcing and managing opportunistic investments and unlocking value from market dislocations and complex opportunities. Disruptive Capital Finance has a wide-ranging investment focus, targeting the waste, recycling, energy efficiency, and biotechnology sectors predominantly within the clean-tech space. With a minimum investment size of £850,000 and a maximum of £10,000,000, they support companies at various growth stages, from Seed to Later Stage, including Startup, Early Stage, and Expansion phases. The fund has achieved a 33% Internal Rate of Return (IRR) on all realized investments over 27 years, demonstrating their strong performance in the venture capital space. Current portfolio highlights of Disruptive Capital include a diverse array of companies such as Atlantic SuperConnection, a green energy project, Brooklyn ImmunoTherapeutics in the bioresearch field, REG Technologies for insurance regulatory compliance, and essDocs for digitizing trade and finance documents, among others. Additionally, Disruptive Capital engages in Positive Impact Investing, focusing on sustainable and beneficial investments. They also maintain involvement in a project transforming high-altitude Alpine land into health destinations and ventures that advance cell and gene therapies.